tiprankstipranks
Advertisement
Advertisement

Shofu’s Margins Lag Despite Modest Sales Growth in Nine-Month Results

Story Highlights
  • Dental-focused manufacturer Shofu grew nine-month revenue just 0.9% to ¥29.1 billion as chemical products offset softer equipment and cement sales.
  • Operating profit slid 11% amid higher R&D spending, yet management maintained full-year guidance, banking on chemical strength and cost discipline to restore margins.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Shofu’s Margins Lag Despite Modest Sales Growth in Nine-Month Results

Meet Samuel – Your Personal Investing Prophet

Shofu Inc. ( (JP:7979) ) has issued an announcement.

While consolidated nine-month sales edged up 0.9% to ¥29.1 billion on steady dental demand, operating income slipped 11% as softer machinery and cement volumes and rising R&D spending weighed on margins even though R&D intensity rose to 5.6%. Management still targets full-year revenue of ¥40.9 billion, suggesting confidence that stronger chemical products and disciplined cost controls can offset weak equipment sales, but investors must watch whether the rebound in profitability materializes given the higher operating leverage embedded in the plan.

The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2060.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.

More about Shofu Inc.

Shofu Inc. operates in the dental materials and equipment industry, supplying artificial teeth, abrasives, cements, chemicals, and related devices alongside a smaller nail care portfolio that relies heavily on overseas demand.

Average Trading Volume: 89,210

Technical Sentiment Signal: Buy

Current Market Cap: Yen65.59B

Learn more about 7979 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1